The impact of maternal prenatal and postnatal anxiety on children's emotional problems: a systematic review
S Rees, S Channon, CS Waters - European child & adolescent psychiatry, 2019 - Springer
Maternal mental health problems during pregnancy and the postnatal period are a major
public health issue. Despite evidence that symptoms of both depression and anxiety are …
public health issue. Despite evidence that symptoms of both depression and anxiety are …
Gestational factors throughout fetal neurodevelopment: the serotonin link
SI Hanswijk, M Spoelder, L Shan, MMM Verheij… - International journal of …, 2020 - mdpi.com
Serotonin (5-HT) is a critical player in brain development and neuropsychiatric disorders.
Fetal 5-HT levels can be influenced by several gestational factors, such as maternal …
Fetal 5-HT levels can be influenced by several gestational factors, such as maternal …
Association of antidepressant use during pregnancy with risk of neurodevelopmental disorders in children
EA Suarez, BT Bateman, S Hernández-Díaz… - JAMA internal …, 2022 - jamanetwork.com
Importance Antidepressant use during pregnancy has been associated with
neurodevelopmental disorders in children in some studies. However, results may be …
neurodevelopmental disorders in children in some studies. However, results may be …
Prenatal antidepressant exposure and offspring brain morphologic trajectory
Importance Clinical decision-making on antidepressant treatment during pregnancy,
particularly selective serotonin reuptake inhibitors (SSRIs), is challenging, as both prenatal …
particularly selective serotonin reuptake inhibitors (SSRIs), is challenging, as both prenatal …
Long-term effects of intrauterine exposure to antidepressants on physical, neurodevelopmental, and psychiatric outcomes: a systematic review
Objective: Reviews on child outcomes following in utero antidepressant exposure have
focused on short-term outcomes. However, several recent individual studies reported on …
focused on short-term outcomes. However, several recent individual studies reported on …
Perinatal selective serotonin reuptake inhibitor (SSRI) and other antidepressant exposure effects on anxiety and depressive behaviors in offspring: a review of findings …
The developmental impact of selective serotonin reuptake inhibitor (SSRI) and other
antidepressant treatments during gestation and postpartum on anxiety and depression …
antidepressant treatments during gestation and postpartum on anxiety and depression …
Risk-benefit balance assessment of SSRI antidepressant use during pregnancy and lactation based on best available evidence–an update
CJ Fischer Fumeaux, M Morisod Harari… - Expert opinion on …, 2019 - Taylor & Francis
Introduction: Depression affects 300 million individuals worldwide. While selective serotonin
reuptake inhibitors (SSRI) are one of the first-line pharmacological treatments of major …
reuptake inhibitors (SSRI) are one of the first-line pharmacological treatments of major …
Safety of psychotropic medications during pregnancy
ER Raffi, R Nonacs, LS Cohen - Clinics in Perinatology, 2019 - perinatology.theclinics.com
Safety of Psychotropic Medications During Pregnancy - Clinics in Perinatology Skip to Main
Content Clinics in Perinatology Log in Register Log in Subscribe Claim Skip menu theclinics.com …
Content Clinics in Perinatology Log in Register Log in Subscribe Claim Skip menu theclinics.com …
In utero exposure to antidepressant medication and neonatal and child outcomes: a systematic review
CA Fitton, MFC Steiner, L Aucott, JP Pell… - Acta Psychiatrica …, 2020 - Wiley Online Library
Objective The aim of this study is to systematically review published studies, reporting
outcomes to offspring following in utero exposure to antidepressant medications, which used …
outcomes to offspring following in utero exposure to antidepressant medications, which used …
[HTML][HTML] Perinatal selective serotonin reuptake inhibitor exposure and behavioral outcomes: a systematic review and meta-analyses of animal studies
AS Ramsteijn, L Van de Wijer, J Rando… - Neuroscience & …, 2020 - Elsevier
Abstract In the Western world, 2–5% of pregnant women use selective serotonin reuptake
inhibitor (SSRI) antidepressants. There is no consensus on the potential long-term …
inhibitor (SSRI) antidepressants. There is no consensus on the potential long-term …